In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs

被引:42
作者
Franzot, SP
Hamdan, JS
机构
关键词
D O I
10.1128/AAC.40.3.822
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 53 Cryptococcus neoformans strains, including clinical and environmental Brazilian isolates, were tested for their susceptibilities to amphotericin B, 5-flucytosine, ketoconazole, fluconazole, and itraconazole. The tests were performed according to the National Committee of Clinical Laboratory Standards recommendations (document M27-P). In general, there was a remarkable homogeneity of results for all strains, and comparable MICs were found for environmental and clinical isolates. This paper represents the first contribution in which susceptibility data for Brazilian C. neoformans isolates are provided.
引用
收藏
页码:822 / 824
页数:3
相关论文
共 24 条
  • [1] 2-SITE COMPARISON OF BROTH MICRODILUTION AND SEMISOLID AGAR DILUTION METHODS FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS IN 3 MEDIA
    ANAISSIE, E
    SHAWAR, R
    PAETZNICK, V
    ENSIGN, LG
    WITTE, Z
    LAROCCO, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) : 1370 - 1372
  • [2] COMPARATIVE-STUDY OF BROTH MACRODILUTION AND MICRODILUTION TECHNIQUES FOR IN-VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS BY USING THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS PROPOSED STANDARD
    BARCHIESI, F
    COLOMBO, AL
    MCGOUGH, DA
    RINALDI, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2494 - 2500
  • [3] INVITRO SUSCEPTIBILITY OF CRYPTOCOCCUS STRAINS TO 5 ANTIFUNGAL DRUGS
    BAVA, AJ
    NEGRONI, R
    [J]. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 1989, 31 (05): : 346 - 350
  • [4] SUSCEPTIBILITIES OF SERIAL CRYPTOCOCCUS-NEOFORMANS ISOLATES FROM PATIENTS WITH RECURRENT CRYPTOCOCCAL MENINGITIS TO AMPHOTERICIN-B AND FLUCONAZOLE
    CASADEVALL, A
    SPITZER, ED
    WEBB, D
    RINALDI, MG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) : 1383 - 1386
  • [5] RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSIS OF CRYPTOCOCCUS-NEOFORMANS ISOLATES FROM ENVIRONMENTAL (PIGEON EXCRETA) AND CLINICAL SOURCES IN NEW-YORK-CITY
    CURRIE, BP
    FREUNDLICH, LF
    CASADEVALL, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) : 1188 - 1192
  • [6] Espinel-Ingroff Ana, 1995, P1405
  • [7] COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KISH, CW
    KERKERING, TM
    FROMTLING, RA
    BARTIZAL, K
    GALGIANI, JN
    VILLAREAL, K
    PFALLER, MA
    GERARDEN, T
    RINALDI, MG
    FOTHERGILL, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) : 3138 - 3145
  • [8] COMPARISON STUDY OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KERKERING, TM
    GOLDSON, PR
    SHADOMY, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) : 1089 - 1094
  • [9] VIRULENCE AND ANTIFUNGAL SUSCEPTIBILITY OF ENVIRONMENTAL AND CLINICAL ISOLATES OF CRYPTOCOCCUS-NEOFORMANS FROM PUERTO-RICO
    FROMTLING, RA
    ABRUZZO, GK
    RUIZ, A
    [J]. MYCOPATHOLOGIA, 1989, 106 (03) : 163 - 166
  • [10] MULTICENTER EVALUATION OF A BROTH MACRODILUTION ANTIFUNGAL SUSCEPTIBILITY TEST FOR YEASTS
    FROMTLING, RA
    GALGIANI, JN
    PFALLER, MA
    ESPINELINGROFF, A
    BARTIZAL, KF
    BARTLETT, MS
    BODY, BA
    FREY, C
    HALL, G
    ROBERTS, GD
    NOLTE, FB
    ODDS, FC
    RINALDI, MG
    SUGAR, AM
    VILLAREAL, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) : 39 - 45